Sun City, ARIZONA5 Active Studies

Crohns Disease Clinical Trials in Sun City, ARIZONA

Find 5 actively recruiting crohns disease clinical trials in Sun City, ARIZONA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
2,372
Enrolling

Recruiting Crohns Disease Studies in Sun City

RecruitingSun City, ARIZONANCT06430801

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1...

1,200 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingSun City, ARIZONANCT06819878

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) i...

600 participants
Hoffmann-La Roche
View Study Details
RecruitingSun City, ARIZONANCT06637631

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

This is a phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of SAR441566 in adults with moderate to severe Crohn...

260 participants
Sanofi
View Study Details
RecruitingSun City, ARIZONANCT06456593

Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase. The objective is to evaluate the efficacy and safety of obefazimod compared t...

212 participants
Abivax S.A.
View Study Details
RecruitingSun City, ARIZONANCT06045754

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

The main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with adalimumab or vedolizumab (VDZ) together with ustekinumab (UST) in adults with mode...

100 participants
Takeda
View Study Details

About Crohns Disease Clinical Trials in Sun City

Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.

There are currently 5 crohns disease clinical trials recruiting participants in Sun City, ARIZONA. These studies are seeking a combined 2,372 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Hoffmann-La Roche, Sanofi and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Crohns Disease Clinical Trials in Sun City — FAQ

Are there crohns disease clinical trials in Sun City?

Yes, there are 5 crohns disease clinical trials currently recruiting in Sun City, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sun City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sun City research site will contact you about next steps.

Are clinical trials in Sun City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sun City studies also compensate for your time and travel.

What crohns disease treatments are being tested?

The 5 active trials in Sun City are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.

Data updated March 2, 2026 from ClinicalTrials.gov